Cargando…
Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
Autores principales: | Ferrara, Francesco, De Rosa, Francesco, Vitiello, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319216/ https://www.ncbi.nlm.nih.gov/pubmed/32838149 http://dx.doi.org/10.1007/s42399-020-00375-0 |
Ejemplares similares
-
The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care Unit
por: Ferrara, Francesco, et al.
Publicado: (2020) -
COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy
por: Vitiello, Antonio, et al.
Publicado: (2020) -
Antidiabetes Agents against Sars-Cov-2 Infection
por: Vitiello, Antonio, et al.
Publicado: (2020) -
Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2021) -
The Impact of COVID-19 Pandemic on Spine Surgeons Worldwide
por: Louie, Philip K., et al.
Publicado: (2020)